Copertina

Identification of human metabolites of fast skeletal troponin activators Tirasemtiv and Reldesemtiv for doping control purposes

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Luisa Euler, Kim Deinert, Felicitas Wagener, Katja Walpurgis, Mario Thevis
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Drug Testing and Analysis
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Investigations Into Structures of In Vitro–Derived Phase I Metabolites of a Novel 20‐Keto‐Steroid S42 by GC‐EI HR MS Analysis and Chemical Synthesis
di: Hui‐Chung Wen, et al.
Pubblicazione: (2025)

Detection of the GH Analogue Redalsomatropin Alfa in Sports Drug Testing: Immunological Approaches and LC‐HRMS/MS
di: Katja Walpurgis, et al.
Pubblicazione: (2026)

The 43rd Manfred Donike Workshop on Doping Analysis
di: Mario Thevis
Pubblicazione: (2026)

Obituary Don H. Catlin
di: Mario Thevis
Pubblicazione: (2024)

Investigations Into the Metabolism and Elimination of Flmodafinil and Fladrafinil for Sports Drug Testing Purposes
di: O. Krug, et al.
Pubblicazione: (2026)

Improving the Determination of Carbon Isotope Ratios of Endogenous Steroids Found in Human Serum
di: Thomas Piper, et al.
Pubblicazione: (2024)

Cost Minimized Immunoaffinity Purification of EPO and Its Analogs in Doping Control—A Step‐by‐Step Protocol for Human Urine and Blood
di: Christian Reichel, et al.
Pubblicazione: (2025)

Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024
di: Mario Thevis, et al.
Pubblicazione: (2024)

Annual Banned‐Substance Review 18th Edition—Analytical Approaches in Human Sports Drug Testing 2024/2025
di: Mario Thevis, et al.
Pubblicazione: (2026)

Gel Electrophoretic Detection of Black Market ACE‐031
di: Christian Reichel, et al.
Pubblicazione: (2025)

Analysis and Characterization of Kisspeptin and Its Analogues in Serum and Urine Samples by Liquid Chromatography–High‐Resolution Mass Spectrometry for Doping Control Purposes
di: Sophia Krombholz, et al.
Pubblicazione: (2026)

Long‐Term Excretion of Roxadustat in Urine
di: Tim Sobolevsky, et al.
Pubblicazione: (2024)

Assessing the Effect of Probiotics in the Steroidal Module of the Athlete's Biological Passport
di: Ana Belen Moraleda Merlo, et al.
Pubblicazione: (2025)

Detection of doping substances in paired dried blood spots and urine samples collected during doping controls in Danish fitness centers
di: Maren Christin Stillesby Levernæs, et al.
Pubblicazione: (2024)

Analytical advances in horseracing medication and doping control from 2018 to 2023
di: Bob Gray, et al.
Pubblicazione: (2024)

Association of Official Racing Chemists guidelines for drug testing in animal hair for doping control
di: Bob Gray, et al.
Pubblicazione: (2024)

Metabolism of highly potent synthetic opioid nitazene analogs: N‐ethyl‐N‐(1‐glucuronyloxyethyl) metabolite formation and degradation to N‐desethyl metabolites during enzymatic hydrolysis
di: Tatsuyuki Kanamori, et al.
Pubblicazione: (2024)

Detection of FG‐4592 and metabolites in equine plasma, urine and hair following oral administration
di: Charlotte Cutler, et al.
Pubblicazione: (2024)

Methylation of phase II metabolites of endogenous anabolic androgenic steroids to improve analytical performance
di: Sandra Pfeffer, et al.
Pubblicazione: (2024)

Comprehensive metabolic investigation of dopamine reuptake inhibitor HDMP‐28 in equine liver microsomes and Cunninghamella elegans for doping control
di: Meleparappil Muhammed Ajeebsanu, et al.
Pubblicazione: (2024)

Advances in SARMs anti‐doping analysis
di: Kristián Slíž, et al.
Pubblicazione: (2024)

Gene doping detection in the era of genomics
di: Ruihong Li, et al.
Pubblicazione: (2024)

Detection of methandienone and its metabolites in equine urine, plasma and hair following a multidose oral administration
di: Marjaana Viljanto, et al.
Pubblicazione: (2024)

Homologous blood transfusion and doping: Where are we now?
di: Alexandre Marchand, et al.
Pubblicazione: (2024)

Detection of the selective androgen receptor modulator S‐23 and its metabolites in equine urine and plasma following oral administration
di: Charlotte Cutler, et al.
Pubblicazione: (2024)

Simultaneous quantitation and identification of intact Nandrolone phase II oxo‐metabolites based on derivatization and inject LC–MS/(HRMS) methodology
di: Panagiotis Sakellariou, et al.
Pubblicazione: (2024)

Beta2‐adrenergic agonist salbutamol exhibits enantioselective disposition in skeletal muscle of lean young men following oral administration
di: Morten Hostrup, et al.
Pubblicazione: (2024)

Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA
di: Rui‐Jia Chen, et al.
Pubblicazione: (2024)

Intelligence‐based anti‐doping via an Intelligence and Drug Testing Management (IDTM) system
di: Wai Him Kwok, et al.
Pubblicazione: (2024)

Interest of hair tests to discriminate a tail end of a doping regimen from a drug transfer between two individuals in case of challenging an anti‐doping rule violation. IV. Case example with mesterolone
di: Pascal Kintz, et al.
Pubblicazione: (2024)

Individual identification method using samples associated with doping tests: A comparison of mitochondrial and nuclear genetic data
di: Kentaro Akiyama, et al.
Pubblicazione: (2024)

Identification of Hexahydrocannabiphorol Metabolites in Human Urine
di: Willi Schirmer, et al.
Pubblicazione: (2025)

Identification of Tetrahydrocannabidiol Metabolites in Human Urine
di: Willi Schirmer, et al.
Pubblicazione: (2025)

Development of 3β,4α‐dihydroxy‐5α‐androstan‐17‐one standard solution for doping analyses
di: Miho Kuroe, et al.
Pubblicazione: (2024)

Elimination profile of low‐dose chlortalidone and its detection in hair for doping analysis—Implication for unintentional non‐therapeutic exposure
di: Detlef Thieme, et al.
Pubblicazione: (2024)

Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo‐Pyridyl Synthetic Cannabinoid Receptor Agonist CH‐FUBBMPDORA
di: Marie H. Deventer, et al.
Pubblicazione: (2025)

Characterization and Identification of Commercial Synthetic Urine Products
di: Patrick B. Kyle, et al.
Pubblicazione: (2025)

Post‐Mortem Identification and Toxicological Findings of Fluetonitazepyne and Isotonitazepyne
di: Pirkko Kriikku, et al.
Pubblicazione: (2025)

Simultaneous detection of three hypoxia‐inducible factor stabilizers—molidustat, roxadustat, and vadadustat—in multiple keratinized matrices and its application in a doping context
di: Anne Checkouri, et al.
Pubblicazione: (2024)

Identification of Metabolites of the Dietary Supplement Ingredient 5α‐Hydroxy‐Laxogenin
di: Daniel Derwand, et al.
Pubblicazione: (2026)